ADHD Medication Management for Adults in New Jersey

Medication management for adult ADHD means more than writing a prescription. It is the ongoing work of choosing a medication, adjusting it, watching for side effects, and keeping prescriptions flowing within the rules. In New Jersey those rules come from three layers at once: federal law on controlled substances, the Board of Medical Examiners' prescribing rule, and the state telehealth law as amended in July 2026. This page lays them out from a patient's point of view. Dr. John C. Shershow, M.D., a psychiatrist licensed in New Jersey and New York, provides medication management for adults with ADHD when medication is appropriate.

The New Jersey rules at a glance

Many ADHD stimulants are Schedule II controlled substances, which is why New Jersey's law speaks of "a stimulant that is a Schedule II controlled dangerous substance." For an adult patient in New Jersey, as of October 2026:

The Board's rule also says what must happen before a physician starts a controlled substance: a thorough history including substance use, an examination appropriate to the condition that also evaluates coexisting conditions such as anxiety and depression, a reasonable effort to get your prior records, a treatment plan, and a medical record of all of it. A fuller explanation of each rule is in ADHD medication rules in New Jersey.

How New Jersey's telehealth rule changed in 2026

• Until February 16, 2026: COVID-era waivers allowed Schedule II prescribing by telemedicine without an in-person visit.
• From February 2026: the Division of Consumer Affairs told prescribers that no new patient could be prescribed a Schedule II substance before an initial in-person visit.
• Since July 8, 2026: P.L.2026, c.40 set the current rule for adults on a Schedule II stimulant: telehealth start allowed, in-person visit within 30 days, a contact every three months, and an in-person visit at least yearly. Telehealth for this purpose must be real-time two-way audio and video, so a phone call alone does not count.
• August 3, 2026: the Division's Drug Control Unit published a notice summarizing the new law for prescribers.

The office will explain how visits are arranged for patients located in New Jersey. See telehealth ADHD prescriptions in New Jersey in 2026.

What the NJPMP is, and who looks at it

New Jersey's Prescription Monitoring Program (NJPMP) lets prescribers and pharmacists see whether a person has received other controlled-substance prescriptions. Beyond the Board's requirement to check it when starting a controlled substance, N.J.A.C. 13:45A-35.9 requires a pharmacist to check it before dispensing a Schedule II drug when the pharmacist reasonably believes the person may be seeking it for misuse or diversion. A prescriber seeing a fill from another prescriber, or an early fill, will usually ask about it. That is routine, and an honest answer is the fastest way through it. More detail: the New Jersey Prescription Monitoring Program and ADHD.

Filling ADHD prescriptions at New Jersey pharmacies

• The pharmacy needs a New Jersey CDS registration. The Drug Control Unit says any pharmacy dispensing controlled substances in New Jersey, including an out-of-state pharmacy, must hold one.
• Partial fills are allowed. Under 21 CFR 1306.13, you or the prescriber can ask for a Schedule II prescription to be partly filled, where state law allows, and the rest can be filled up to 30 days after the prescription was written. That can help when a pharmacy has only part of the quantity.
• Transfers are limited in New Jersey. Since August 28, 2023, federal rules allow a one-time transfer of an unfilled electronic Schedule II prescription for the initial fill, but New Jersey's Board of Pharmacy rule says a Schedule II prescription may not be transferred between pharmacies (N.J.A.C. 13:39-7.8(c)). At a New Jersey pharmacy, expect to need a new prescription to switch stores.
• Shortages are still real. As of mid-October 2026, the FDA's drug shortage database lists mixed amphetamine salts tablets, lisdexamfetamine and extended-release methylphenidate tablets as current shortages. Call the pharmacy before a prescription is sent to confirm the exact medication and strength are in stock.

New Jersey's Board of Pharmacy rule says a pharmacist shall fill a prescription from a practitioner authorized to prescribe in another state (N.J.A.C. 13:39-7.1), though the pharmacist may refuse one he or she has cause to doubt (N.J.A.C. 13:39-7.13). Ask the pharmacy before the prescription is sent. Practical steps are in filling ADHD prescriptions at New Jersey pharmacies.

What happens between visits

Because Schedule II prescriptions cannot be refilled, each month's supply needs a new prescription, or a set of dated prescriptions written at one visit. Plan around that:

• Keep track of when your supply will run out, and contact the office several days before, not the day of.
• Use one pharmacy when you can. It makes the PMP record simple and stock problems easier to solve.
• Report side effects to the office when they happen rather than waiting for the next visit.
• Do not share medication. The FDA tells prescribers to counsel patients not to share stimulants, and its 2023 boxed warning update covers misuse, addiction and overdose risks.

What a follow-up covers is explained in ADHD follow-up visits in New Jersey.

A new medication in 2026

The FDA approved centanafadine (Simtriyo) on July 24, 2026. As of October 2026, DEA scheduling was pending, so how New Jersey's controlled-substance rules apply to it was not yet settled. The available medication types are compared in stimulant vs nonstimulant ADHD medication.

Starting medication management

Medication management starts with an evaluation, or with a review of an existing diagnosis and records if you are already on medication. Bring your current prescription details, pharmacy name and any prior records. No prescription is guaranteed. Medication is considered when it is appropriate. For fees, the office can tell you the current fees and how insurance works with the practice.